Healthcare -
Biotechnology - NASDAQ - US
$ 2.85
-5.94 %
$ 182 M
Market Cap
-2.48
P/E
LRMR - OTHER CURRENT LIABILITIES
Other Current Liabilities LRMR - Larimar Therapeutics, Inc.
7.39 M
LAST VALUE
10.97%
2 YEAR CAGR
1.25%
5 YEAR CAGR
9.74%
10 YEAR CAGR